Liver Transplant Patients Faced Hepatitis B Vaccine Gap
A new study found 40% of U.S. liver transplant recipients lacked hepatitis B vaccination, highlighting an urgent need for better care.
Updated on Sept. 30, 2026 in COVID-19
Live Poll
Do you trust that health systems effectively provide necessary preventive care to patients with serious illnesses?
Researchers determined that 40% of 13,851 liver transplant recipients analyzed in the U.S. were not vaccinated against hepatitis B. This gap suggests that many patients with severe liver disease miss critical immunization opportunities before receiving a transplant.
Why it matters
Patients with severe liver disease often have shorter waitlist times, which can leave them with little time to complete the hepatitis B vaccination series. Missing this protection can increase health risks after surgery, making rapid immunization strategies a priority for transplant centers.
A multivariable analysis of 13,851 liver transplant recipients from September 2022 to June 2024 found that 40% lacked hepatitis B vaccination. The study identified factors including older age, alcohol-associated liver disease, and higher MELD-Na scores as correlates for lower vaccine uptake.
The players
United Network for Organ Sharing
The private, non-profit organization that manages the United States organ transplant system and maintains national data on transplant recipients.
Baylor College of Medicine
A health sciences university and research institution that led the analysis of transplant data.
The details
Researchers determined vaccination status by evaluating patient records for self-reported vaccine history or laboratory evidence of hepatitis B antibodies. The analysis suggests that patients with higher MELD-Na scores—a measure of illness severity—often reach their transplant window too quickly to complete the standard series. Implementing accelerated vaccination strategies could help ensure more candidates achieve immunity before their procedure.
Timeline
2021: The United Network for Organ Sharing began requiring the reporting of patient vaccination status.
September 2022 to June 2024: Researchers analyzed data from liver transplant recipients.
September 29, 2026: The study results were published in Clinical Infectious Diseases.
Health Landscape
This research provides a necessary update on vaccine coverage following the implementation of mandatory reporting by the United Network for Organ Sharing. It signals a shift toward identifying specific patient populations who may benefit from accelerated clinical workflows to improve transplant safety.
If you or a family member are currently on a liver transplant waitlist, it is worth discussing your hepatitis B vaccination status and timeline with your care team. Proactively asking about accelerated immunization protocols can help ensure all preventive care is addressed before surgery.
The takeaway
The study highlights that many liver transplant candidates miss out on essential hepatitis B protection due to shortened waitlist timelines. Patients should confirm their vaccination status with their transplant coordinator as part of their pre-surgical planning.
Further reading
For broader information on vaccine management and disease prevention, explore our COVID-19 resources.
Source note: This article includes information reported by Umn.
Live Poll
Do you trust that health systems effectively provide necessary preventive care to patients with serious illnesses?
